Share

FDA Approves New Treatment for Osteoporosis in Postmenopausal Women at High Risk of Fracture

The U.S. Food and Drug Administration has approved romosozumab-aqqg to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture). These are women with a history of osteoporotic fracture or multiple risk factors for fracture, or those who have failed or are intolerant to other osteoporosis therapies. The drug will be marketed...
Share

Q&A: Clifford Rosen, MD: Practice Guideline on Pharmacological Treatment of Osteoporosis in Post-Menopausal Women

Clifford Rosen Endocrine News talks with Clifford Rosen, MD, chair of the task force that created the latest Endocrine Society Clinical Practice Guideline on Pharmacological Management of Osteoporosis in Post-Menopausal Women. In March, the Endocrine Society issued a Clinical Practice Guideline on treating post-menopausal women with osteoporosis. Titled “Pharmacological Management of Osteoporosis in Post-Menopausal Women: An Endocrine...
Share

Childhood Exposure to Passive Smoking Linked to Impaired Bone Health in Adulthood

Children of parents who smoke have evidence of impaired bone health in adulthood, according to a study recently published in The Journal of Clinical Endocrinology and Metabolism. Researchers led by Markus Juonala, MD, PhD, of the University of Turku and Division of Medicine, Turku University Hospital, and FinlandMurdoch Childrens Research Institute in Parkville, Victoria, Australia,...